UroToday23h
ASCO GU 2025: Age-Related Efficacy and Safety of Darolutamide + ADT and Docetaxel in Patients with mHSPC: A Subgroup Analysis of ARASENS
(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Joan Carles discussing a subgroup analysis of ARASENS assessing age-related efficacy and ...
UroToday23h
ASCO GU 2025: Capturing What You Cannot See: How Can ctDNA Be Used to Improve Clinical Staging for Upper Tract Disease?
(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13th and 15th 2025, was host to the Panning for Gold: ...